Oncology Advances - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image illustrating rising takeover speculation around Papa John’s International, Inc., as renewed private equity interest and a reported $65-per-share bid from TriArtisan Capital Advisors push the PZZA stock back into focus amid ongoing turnaround efforts.

Papa John’s agrees to explore sale as renewed private equity interest lifts PZZA

$Bristol Myers Squibb's Breyanzi, a CAR T cell therapy, received FDA accelerated approval for treating relapsed or refractory follicular lymphoma, offering hope for lasting remission.$

Read More

2 minute read

Pharma Industry News

FDA grants accelerated approval to Bristol Myers Squibb’s Breyanzi for follicular lymphoma

Bristol Myers Squibb (NYSE: BMY) has announced a significant breakthrough in the treatment of follicular lymphoma with the…

byPallavi Madhiraju

May 16, 2024

web analytics